News

Investor Alert: Taking Action Against Easterly ROCMuni Fund Losses

Investor Alert: Taking Action Against Easterly ROCMuni Fund Losses

Investors Take Notice: Class Action Lawsuit Against Easterly ROCMuni Fund

Investors who purchased shares of the Easterly ROCMuni High Income Municipal Bond Fund (NYSE: RMJAX; RMHVX; RMHIX) should be aware of a class action lawsuit that is gaining attention. This legal action is open to those who acquired shares between certain dates and faced significant financial losses.

Details of the Class Action Lawsuit

The lawsuit, formally titled Victorson v. James Alpha Funds Trust d/b/a Easterly Funds Trust, No. 25-cv-06028 (S.D.N.Y.), puts a spotlight on serious allegations regarding the fund's management. Plaintiffs claim that during the Class Period, the fund's management made substantial misrepresentations regarding the value and stability of its portfolio.

Key Allegations Against the Fund

The class action lawsuit puts forth several allegations regarding the fund's operations. Notably, it is claimed that the Easterly ROCMuni Fund reported inflated prices for its assets, which did not truly represent their fair market value. This misinformation led to a misrepresentation of the fund's net asset value (NAV) and potential risks associated with its investment strategies.

Specifically, the allegations state that the fund utilized a faulty pricing methodology that resulted in artificial inflation of its NAV. Furthermore, it was revealed that the fund had more illiquid assets than were disclosed, increasing its risk profile significantly.

Impact of Recent Market Movements

In a startling turn of events on June 13, 2025, the fund marked down its shares by 30%. For instance, RMHIX saw its NAV drop from $6.15 to $4.33 in just one day. Similarly, RMHVX and RMJAX experienced similar declines. The legal action follows these abrupt losses, which have left many investors financially impacted.

Understanding the Role of a Lead Plaintiff

The Private Securities Litigation Reform Act of 1995 allows any investor purchasing shares during the specified period to be considered for the position of lead plaintiff in the lawsuit. The chosen lead plaintiff will represent the interests of all investors involved.

Who Can Be a Lead Plaintiff?

To qualify as a lead plaintiff, an investor must demonstrate that they possess the greatest financial interest in the issue at hand and that their claims are typical of those of the entire class. Notably, becoming a lead plaintiff does not impact one’s ability to benefit from a potential settlement or recovery associated with the class action.

About Robbins Geller Rudman & Dowd LLP

Robbins Geller Rudman & Dowd LLP stands out as a leading law firm focused on securities fraud and shareholder litigation. The firm has built a reputable standing, having secured substantial recoveries for investors in securities-related class actions, making them an experienced choice for representation in this lawsuit.

With a dedicated team of attorneys, Robbins Geller has a proven history of winning significant settlements on behalf of investors. Their extensive experience in handling complex legal matters positions them as effective advocates for those affected by the challenges faced by the Easterly ROCMuni Fund.

Frequently Asked Questions

What is the Easterly ROCMuni Fund?

The Easterly ROCMuni Fund is a mutual fund that aims to provide high-yield returns by investing in high-yield municipal bonds.

Why is there a class action lawsuit against the fund?

The lawsuit alleges that the fund's management misrepresented asset values and risks, which led to significant financial losses for investors.

Who can join the class action lawsuit?

Investors who purchased shares during the specified class period and experienced losses can seek to join the class action.

What does being a lead plaintiff involve?

A lead plaintiff represents the interests of all class members and directs the lawsuit, but you do not have to be a lead plaintiff to benefit from potential recoveries.

How can I contact Robbins Geller for more information?

You can reach out to them by phone at 800-449-4900 for inquiries regarding the lawsuit or your investment situation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 194

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 96

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 104

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 222

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 168

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 138

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 130

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading

Top 5 Most Recently Viewed Articles

Transformative Innovations in AI-Driven Data Center Patenting

Updated Category News Views 238

Insights from the Latest PatentVest Pulse Report In an era where digital advancements are at an all-time high, PatentVest has unveiled their latest findings in the PatentVest Pulse Report. This enlightening report delves into the transformative trends emerging in the AI data center patent landscape. With growing demands for efficient data handling and innovative...

Continue Reading
TransUnion's Q4 Earnings Beat Expectations; Analysts React

Updated Category News Views 232

TransUnion's Impressive Fourth Quarter Earnings TransUnion reported upbeat earnings for the fourth quarter, showcasing a strong performance that caught the attention of market analysts. The company announced earnings of $1.07 per share, surpassing the analyst consensus estimate of $1.02. In addition, quarterly sales rose to $1.171 billion, exceeding expectations of $1.134...

Continue Reading
Tencent Music Entertainment Group Announces Q3 2025 Results Update

Updated Category News Views 333

Tencent Music Entertainment Group to Report Financial Results Tencent Music Entertainment Group (NYSE: TME), a prominent name in the realm of online music and audio entertainment, has made a significant announcement regarding its upcoming financial results. The company is gearing up to reveal its unaudited financial performance for the third quarter of 2025, a vital time...

Continue Reading
AiDash's New Leadership Team Drives Growth and Innovation

Updated Category News Views 132

AiDash's New Leadership Team Drives Growth and Innovation AiDash, an enterprise SaaS company focused on making critical infrastructure industries climate adaptive and resilient, has recently taken significant steps to expand its leadership team. This move comes at a vital time as the company continues to scale its operations, aiming to meet the rising demand for...

Continue Reading
Daily Market Insights: Trading Strategies for Major Stocks

Updated Category News Views 391

Daily Market Trading Strategies for Success Good morning, traders! Today, we’re diving into insights on crucial stocks such as SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. Our goal is to discuss effective strategies and essential price levels to help you navigate the market with confidence. Market Analysis: Key Price Levels to Watch Using our exclusive formula at...

Continue Reading